Key points are not available for this paper at this time.
This review summarizes the unmet needs for translational studies on the pathogenesis of AH, preclinical translational tools, and emerging drug targets to benefit the AH patient. (Hepatology 2016;64:1343-1355).
Mandrekar et al. (Sat,) studied this question.